King Luther Capital Management Corp decreased its position in Stericycle (NASDAQ:SRCL) by 27.5% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 10,565 shares of the business services provider’s stock after selling 4,000 shares during the period. King Luther Capital Management Corp’s holdings in Stericycle were worth $618,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Cornerstone Capital Management Holdings LLC. raised its stake in shares of Stericycle by 11.8% during the 4th quarter. Cornerstone Capital Management Holdings LLC. now owns 16,051 shares of the business services provider’s stock worth $1,090,000 after purchasing an additional 1,690 shares in the last quarter. Roberts Glore & Co. Inc. IL bought a new stake in shares of Stericycle during the 4th quarter worth approximately $210,000. Meag Munich Ergo Kapitalanlagegesellschaft MBH bought a new stake in shares of Stericycle during the 4th quarter worth approximately $279,000. Wells Fargo & Company MN raised its stake in shares of Stericycle by 48.6% during the 4th quarter. Wells Fargo & Company MN now owns 2,821,600 shares of the business services provider’s stock worth $191,840,000 after purchasing an additional 922,641 shares in the last quarter. Finally, W.G. Shaheen & Associates DBA Whitney & Co raised its stake in shares of Stericycle by 2,001.2% during the 4th quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 71,967 shares of the business services provider’s stock worth $4,893,000 after purchasing an additional 68,542 shares in the last quarter. Hedge funds and other institutional investors own 96.99% of the company’s stock.
Stericycle opened at $63.86 on Tuesday, MarketBeat.com reports. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 0.88. The company has a market cap of $5.46 billion, a P/E ratio of 14.71, a price-to-earnings-growth ratio of 1.43 and a beta of 0.39. Stericycle has a 1-year low of $56.64 and a 1-year high of $84.74.
Stericycle (NASDAQ:SRCL) last posted its earnings results on Thursday, May 3rd. The business services provider reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.16. The business had revenue of $895.00 million for the quarter, compared to analyst estimates of $880.48 million. Stericycle had a return on equity of 14.14% and a net margin of 0.19%. The firm’s revenue was up .3% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.09 EPS. equities analysts forecast that Stericycle will post 4.63 EPS for the current year.
In other Stericycle news, Director Thomas D. Brown sold 13,210 shares of the company’s stock in a transaction on Wednesday, May 16th. The stock was sold at an average price of $63.37, for a total value of $837,117.70. Following the transaction, the director now directly owns 14,705 shares of the company’s stock, valued at approximately $931,855.85. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jack W. Schuler acquired 10,000 shares of the firm’s stock in a transaction on Thursday, March 1st. The stock was purchased at an average cost of $62.59 per share, for a total transaction of $625,900.00. The disclosure for this purchase can be found here. 3.50% of the stock is currently owned by insiders.
A number of equities research analysts have recently issued reports on SRCL shares. BidaskClub upgraded Stericycle from a “hold” rating to a “buy” rating in a research note on Wednesday, March 21st. ValuEngine lowered Stericycle from a “hold” rating to a “sell” rating in a report on Monday, April 2nd. Robert W. Baird raised Stericycle from an “underperform” rating to a “neutral” rating and set a $73.00 target price on the stock in a report on Tuesday, February 13th. Barrington Research reissued a “buy” rating on shares of Stericycle in a report on Monday, February 26th. Finally, BMO Capital Markets reissued a “hold” rating and set a $72.00 target price on shares of Stericycle in a report on Wednesday, January 24th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and five have given a buy rating to the company’s stock. Stericycle currently has an average rating of “Hold” and an average target price of $78.63.
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.